project . 2016 - 2022 . On going

EuroNanoMed III

ERA-NET ON NANOMEDICINE
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 723770 Call for proposal: H2020-NMBP-ERA-NET-2016
  • Funded under: H2020 | ERA-NET-Cofund Overall Budget: 15,270,000 EURFunder Contribution: 5,039,100 EUR
  • Status: On going
  • Start Date
    01 Nov 2016
    End Date
    31 Oct 2022
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure t...
Description
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure t...
Any information missing or wrong?Report an Issue